|
As shown in the table below, the following stock options, restricted stock units and performance stock units outstanding as of September 30, 2022, have not been included in the calculation of diluted income (loss) per common share for the three and nine months ended September 30, 2022 and 2021 because they will be anti-dilutive to the calculation of diluted net income (loss) per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (In thousands) |
|
Three Months Ended September 30, |
|
|
2022 |
|
2021 |
| Stock options |
|
488 |
|
|
962 |
|
| Restricted stock units |
|
615 |
|
|
1,435 |
|
| Performance stock units |
|
— |
|
|
1,586 |
|
| Total |
|
1,103 |
|
|
3,983 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (In thousands) |
|
Nine Months Ended September 30, |
|
|
2022 |
|
2021 |
| Stock options |
|
488 |
|
|
962 |
|
| Restricted stock units |
|
1,189 |
|
|
1,435 |
|
| Performance stock units |
|
1,758 |
|
|
1,586 |
|
| Total |
|
3,435 |
|
|
3,983 |
|
|